|52 Week Rng||-|
|P/E Ratio (TTM)||-|
|P/E Ratio (Fwd)||-|
|Div & Yield||-|
Johnson & Johnson is a healthcare giant in the United States known for its large range of drugs in multiple therapeutic areas, including oncology, immunology, infectious diseases, neuroscience, and others. It also makes medical devices, including orthopedics. Johnson & Johnson has been seen as a safe stock for a long time, outperforming the S&P 500 with a modest 3 % decline year to date, while S&P was down 23 %. Johnson & Johnson’s sales have shown resilience and with the long-term stability it offers, we see Johnson & Johnson being a great addition as a defensive healthcare value stock.
JNJ is one of the biggest producers of OTC medication in the EM. Historically, the start of the winter sees a massive increase in the price of the stock due to improved earnings.